Results 161 to 170 of about 12,590 (214)

Causality Assessment for Suspected DILI During Clinical Phases of Drug Development [PDF]

, 2014

core   +1 more source

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury [PDF]

, 2015
Abhasnee Sobhonslidsuk, Ammarin Thakkinstian, Chote Luangchosiri, Sermsiri Chitphuk, Supanna Petraksa, Wasana Stitchantrakul   +5 more
core   +1 more source

Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends. [PDF]

Medicine (Baltimore), 2019
Danjuma MI, Sajid J, Fatima H, Elzouki AN.   +3 more
europepmc   +1 more source

Evolution of the Food and Drug Administration Approach to Liver Safety Assessment for New Drugs: Current Status and Challenges [PDF]

, 2014

core   +1 more source

Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria [PDF]

, 2016
Alec Salminen, James Greenhaw, Jun Zhang, Lijun Ren, Matthew Bryant, Matthew White, Qiang Shi, Qiangen Wu, Thomas Papoian, William Mattes, William Salminen, Xi Yang, Yong Luo   +12 more
core   +1 more source

Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China. [PDF]

Med Sci Monit, 2019
Li X, Wang L, Li D, Niu J, Gao P.
europepmc   +1 more source

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery. [PDF]

PLoS One, 2017
Peta V, Tse C, Perazzo H, Munteanu M, Ngo Y, Ngo A, Ramanujam N, Verglas L, Mallet M, Ratziu V, Thabut D, Rudler M, Thibault V, Schuppe-Koistinen I, Bonnefont-Rousselot D, Hainque B, Imbert-Bismut F, Merz M, Kullak-Ublick G, Andrade R, van Boemmel F, Schott E, Poynard T, Drug Induced Liver Injury- Groupe Hospitalier Pitié-Salpêtrière, Drug Induced Liver Group of the Injury Safer and Faster Evidence-based Translation consortium.   +24 more
europepmc   +1 more source

Drug-induced liver injury due to potassium iodide during thyroid storm. [PDF]

JCEM Case Rep
Takano N, Seki Y, Watanabe D, Ichihara A.   +3 more
europepmc   +1 more source

Efficacy and safety of glucocorticoids for acute drug-induced liver injury with hyperbilirubinemia: protocol of a multicenter randomized controlled trial. [PDF]

Ther Adv Gastroenterol
Li Q, Lin Y, Zeng X, Zhou L, Wang F, Ye Q, Gao Y, Guo L, Zhu J, Li J, Li Y, Shao L, Hu Y, Xiao J, Jia A, Wang D, Chang L, Wang J, Zhang J, Wang R, Gao F, Wu Q, Hu P, Zhu C, Cai L, Ran Y, Li Y, Zhang J, Ran Y, Wang C, Wang N, Zhang J, Zhang X, Li J, Sun J, Chu Y, Ma Y, Wang T, Zheng Z, Shen Y, Qi X, Xie W.   +41 more
europepmc   +1 more source

Aspartate aminotransferase and model for end-stage liver disease reliably predict mortality in drug-induced liver injury. [PDF]

Sci Rep
Weber S, Mircheva I, Balakumar R, Allgeier J, Saka D, Donga N, Lange CM, Gerbes AL.   +7 more
europepmc   +1 more source